Whole Blood Leukocyte Mitogen Activated Protein Kinases Activation Differentiates Intensive Care Unit Patients With Systemic Inflammatory Response Syndrome and Sepsis
- 1 April 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Trauma: Injury, Infection & Critical Care
- Vol. 62 (4) , 805-811
- https://doi.org/10.1097/01.ta.0000259267.74789.9b
Abstract
Introduction: We sought to determine whether leukocytes from intensive care unit (ICU) patients have altered ERK and p38 kinase activation and specifically if septic patients manifest changes of endotoxin (lipopolysaccharide [LPS]) tolerance. In vitro pretreatment of monocytes (Mono) with LPS induces LPS tolerance with impaired cytokine release and inhibition of ERK and p38 activation after LPS rechallenge. Hypothesis: We hypothesized that macrophage dysregulation, similar to that seen with in vitro LPS tolerance, occurs in critically ill patients with severe sepsis. Methods: Heparinized whole blood from 16 surgical ICU patients and 16 healthy controls was incubated for 15 minutes ± 10 ng/mL LPS at 37°C. Mono and neutrophil (polymorphonuclear leukocytes [PMN]) diphospho (active) ERK and p38 kinase activation were determined using flow cytometry with monoclonal antibodies. Results are expressed as mean ± SEM of basal and percentage change (delta %) in positive cells (delta = LPS stimulated − basal). χ2 test was used for statistics. Results: Basal ERK was seen in Mono from all groups, but delta % positive only increased in healthy subjects and systemic inflammatory response syndrome (SIRS) patients. No basal Mono or PMN p38 was seen in healthy controls, but LPS significantly activated p38 in both cell types. Mono from patients with sepsis, but not SIRS, had impaired ERK activation. Both PMN and Mono from patients with SIRS had low basal but high LPS-stimulated p38, whereas p38 activation was impaired in patients with sepsis. Conclusion: Alterations in mitogen activated protein kinases (MAPK) activation are seen in ICU patients. Leukocytes of septic patients, but not those with SIRS, showed characteristics of LPS tolerance. Assessment of leukocyte MAPK activation may identify and differentiate patients with sepsis from those with SIRS.Keywords
This publication has 26 references indexed in Scilit:
- Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shockCritical Care Medicine, 2004
- Endotoxin tolerance: is there a clinical relevance?Innate Immunity, 2003
- Endotoxin tolerance: A reviewCritical Care Medicine, 2002
- Toll-like receptorsCritical Care Medicine, 2002
- The nonspecific nature of endotoxin toleranceTrends in Microbiology, 1995
- Macrophage Endotoxin Tolerance: Effect of TNF or Endotoxin PretreatmentJournal of Surgical Research, 1994
- Pathogenesis and Potential Strategies for Prevention and Treatment of Septic Shock: An UpdateClinical Infectious Diseases, 1994
- Multiple Organ Failure Syndrome in the 1990sPublished by American Medical Association (AMA) ,1994
- Endotoxin tolerance: In vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional levelCellular Immunology, 1992
- Multiple-Organ-Failure SyndromeArchives of Surgery, 1986